JP Morgan Chase’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.75M Sell
282,963
-2,728
-1% -$45.3K ﹤0.01% 3593
2025
Q4
$5.04M Buy
285,691
+48,115
+20% +$796K ﹤0.01% 3303
2025
Q3
$3.74M Buy
237,576
+3,323
+1% +$46.7K ﹤0.01% 3610
2025
Q2
$2.6M Buy
234,253
+155
+0.1% +$1.81K ﹤0.01% 3706
2025
Q1
$2.73M Sell
234,098
-21,243
-8% -$273K ﹤0.01% 3632
2024
Q4
$3.49M Buy
255,341
+6,194
+2% +$89.8K ﹤0.01% 3696
2024
Q3
$4.16M Buy
249,147
+62,914
+34% +$919K ﹤0.01% 3346
2024
Q2
$2.21M Buy
186,233
+12,933
+7% +$148K ﹤0.01% 3702
2024
Q1
$2.08M Buy
173,300
+13,202
+8% +$196K ﹤0.01% 3814
2023
Q4
$2.7M Sell
160,098
-14,367
-8% -$203K ﹤0.01% 3600
2023
Q3
$2.61M Sell
174,465
-2,647
-1% -$44.7K ﹤0.01% 3354
2023
Q2
$3.34M Sell
177,112
-3,457
-2% -$54.9K ﹤0.01% 3168
2023
Q1
$3.23M Buy
180,569
+22,113
+14% +$369K ﹤0.01% 3161
2022
Q4
$1.32M Sell
158,456
-334,848
-68% -$2.5M ﹤0.01% 3869
2022
Q3
$3.37M Buy
493,304
+259,845
+111% +$4.32M ﹤0.01% 3064
2022
Q2
$4.57M Buy
233,459
+138,959
+147% +$2.91M ﹤0.01% 2857
2022
Q1
$2.05M Sell
94,500
-13,045
-12% -$277K ﹤0.01% 3731
2021
Q4
$2.53M Sell
107,545
-4,092
-4% -$97.9K ﹤0.01% 3668
2021
Q3
$2.92M Sell
111,637
-9,226
-8% -$223K ﹤0.01% 3474
2021
Q2
$2.93M Buy
120,863
+45,706
+61% +$1.12M ﹤0.01% 3504
2021
Q1
$1.88M Buy
75,157
+6,469
+9% +$171K ﹤0.01% 3773
2020
Q4
$1.89M Buy
+68,688
New +$1.84M ﹤0.01% 3514

Other funds holding SHC

JP Morgan Chase's SHC Position: Q1 2026 in Review

JP Morgan Chase reduced its Sotera Health (SHC) stake by 0.95% in Q1 2026, selling an estimated $45.3K and leaving 282,963 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

JP Morgan Chase first reported a position in SHC in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.04M in Q4 2025. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • JP Morgan Chase held 282,963 shares of Sotera Health worth $3.75M as of Q1 2026.
  • JP Morgan Chase sold 2,728 Sotera Health shares in Q1 2026, an estimated $45.3K.
  • Sotera Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3593 holding.
  • JP Morgan Chase first reported a position in Sotera Health in Q4 2020 and has held it in 22 quarters since.
  • JP Morgan Chase's Sotera Health position peaked at $5.04M in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.